oral semaglutide launch Here's Novo Nordisk's First Obesity Drug In Europe With Proven Heart Health Impact Oral Semaglutide for Weight Loss

Visceral fat, the primary driver of obesity-related cardiovascular risk, begins declining within weeks of starting treatment

Weight Loss: Due to its appetite-suppressing effects, patients often see significant weight loss, which can also help improve other health markers such as blood pressure and cholesterol levels

Semaglutide and tirzepatide are no different

Whilst this might seem desirable, excessively rapid weight loss (generally defined as more than 0.51 kg per week after the initial period) can be associated with gallstone formation, muscle loss, and nutritional deficiencies

How to inject Semaglutide safely and effectively Its normal to be a little anxious about the idea of injecting yourself, but its really a very straightforward process